• 作者：Miguel Á ; ngel Royo Bordonada^a ; ^{mroyo@isciii.es} ; Jos&#233 ; Marí ; a Lobos Bejarano^b ; Jesú ; s Millá ; n Nú ; ñ ; ez-Cort&#233 ; s^c ; Fernando Villar Á ; lvarez^c ; Carlos Brotons Cuixart^d ; Miguel Camafort Babkowski^e ; Carlos Guijarro Herrá ; iz^c ; Carmen de Pablo Zarzosa^f ; Juan Pedro-Botet Montoya^c ; Ana de Santiago Nocito^g ; en nombre del Comité ; Españ ; ol Interdisciplinario para la Prevenció ; n Cardiovascular (CEIPC)^&loz ; ;
• 关键词：prevenció ; n cardiovascular ; dislipemia ; guí ; as de prá ; ctica clí ; nica
• 刊名：Medicina Cl铆nica
• 出版年：2011
• 期刊代码：pca254_00257753
• 类别：med
• 出版时间：11 June 2011
• 卷：137
• 期：1
• 页码：30.e1-30.e13
• 文件大小：1247 K

In Spain, where cardiovascular disease (CVD) is the leading cause of death, hypercholesterolemia, one of the most prevalent risk factors in adults, is poorly controlled. Dyslipidemia should not be approached in isolation, but in the context of overall cardiovascular risk (CVR). Measurement of CVR facilitates decision making, but should not be the only tool nor should it take the place of clinical judgment, given the limitations of the available calculation methods. This document, prepared by the Interdisciplinary Spanish Committee on Cardiovascular Prevention, at the proposal of the Spanish Society of Arteriosclerosis, reviews the cardiovascular prevention activities of the regional health authorities, scientific societies and medical professionals. An initiation of a national strategy on cardiovascular prevention is proposed based on lifestyle modification (healthy diet, physical activity and smoking cessation) through actions in different settings. At the population level, regulation of food advertising, elimination of trans fats and reduction of added sugar are feasible and cost-effective interventions to help control dyslipidemias and reduce CVR. In the health setting, it is proposed to facilitate the application of guidelines, improve training for medical professionals, and include CVR assessment among the quality indicators. Scientific societies should collaborate with the health authorities and contribute to the generation and transmission of knowledge. Finally, it is in the hands of professionals to apply the concept of CVR, promote healthy lifestyles, and make efficient use of available pharmacological treatments.